AMGN
47
16
EMC
80
9
GME
54
3
FIS
75
3
BAC
65
2
AAL
23
-6
ADSK
48
5
FDX
37
4
CVS
64
2
ZBH
66
3
HAS
44
2
IFF
50
8
NWL
44
11
F
56
2
KHC
42
4
DE
62
2
COST
48
5
AAP
26
2
URI
48
8
TRIP
44
7
AMGN
47
16
EMC
80
9
GME
54
3
FIS
75
3
BAC
65
2
AAL
23
-6
ADSK
48
5
FDX
37
4
CVS
64
2
ZBH
66
3
HAS
44
2
IFF
50
8
NWL
44
11
F
56
2
KHC
42
4
DE
62
2
COST
48
5
AAP
26
2
URI
48
8
TRIP
44
7
Financhill
Back

Seres Therapeutics Stock Predictions

Economy going through a "period of transition" - Your portfolio doesn't have to

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40

MCRB
Seres Therapeutics

Last Price:
$0.75
Seasonality Move:
-0.88%

7 Day Trial

ALL ACCESS PASS

$ 7

The Tariff-Proof Asset in Your Pocket

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Seres Therapeutics Stock Forecast

  • Is Seres Therapeutics Stock Undervalued?
    The current Seres Therapeutics [MCRB] share price is $0.74. The Score for MCRB is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • MCRB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Seres Therapeutics Stock Go Up Next Year?

Data Unavailable

Seres Therapeutics Stock Rating

Data Unavailable

Seres Therapeutics Stock Price History

Is MCRB stock going to rise?

  • The current trend is relatively stagnant and MCRB is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
serestherapeutics.com

52-Week Data

52-Week High:
1.53
52-Week Low:
0.54

Prediction Charts

Market Cap:
128.7M
Price in USD:
0.74
Volume:
685.9K
Beta:
2.07

Technical Analysis

SMA50:
0.80
SMA100:
0.80
SMA200:
0.88
52-Wk Change:
-6.08%

Stock Predictions

  • Is Seres Therapeutics stock public?
    Yes, Seres Therapeutics is a publicly traded company.
  • What is the Seres Therapeutics stock quote today?
    The Seres Therapeutics stock price is 0.74 USD today.
  • How to buy Seres Therapeutics stock online?
    You can buy Seres Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-25 0.79 0.77 0.80 0.76
Feb-26 0.76 0.75 0.79 0.72
Feb-27 0.79 0.73 0.79 0.72
Feb-28 0.72 0.76 0.77 0.72
Mar-3 0.76 0.75 0.78 0.73
Mar-4 0.72 0.67 0.73 0.63
Mar-5 0.69 0.76 0.77 0.68
Mar-6 0.75 0.74 0.76 0.72
Mar-7 0.73 0.77 0.77 0.72
Mar-11 0.71 0.72 0.75 0.70
Mar-12 0.72 0.69 0.75 0.68
Mar-13 0.68 0.64 0.70 0.62
Mar-14 0.65 0.69 0.69 0.64
Mar-17 0.71 0.74 0.74 0.69

Seres Therapeutics Earnings

Data Unavailable

Seres Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.16 per share, an increase this year of $0.35 per share, and a decrease next year of $0.20 per share.

* Seres Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.